Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

Background: Health technology assessment (HTA) has increased in importance in supporting payer decision making by assessing the relative effectiveness and cost effectiveness of new medicines. Thus, pharmaceutical companies need to address the HTA requirements early during development to improve reim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, McAuslane, Neil, Liberti, Lawrence, Gardarsdottir, Helga, Goettsch, Wim, Leufkens, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775670/
https://www.ncbi.nlm.nih.gov/pubmed/33390978
http://dx.doi.org/10.3389/fphar.2020.594549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775670/
https://www.ncbi.nlm.nih.gov/pubmed/33390978
http://dx.doi.org/10.3389/fphar.2020.594549

Ejemplares similares